BMC Biology (Oct 2022)

Activation function 1 of progesterone receptor is required for progesterone antagonism of oestrogen action in the uterus

  • Shi Hao Lee,
  • Chew Leng Lim,
  • Wei Shen,
  • Samuel Ming Xuan Tan,
  • Amanda Rui En Woo,
  • Yeannie H. Y. Yap,
  • Caitlyn Ang Su Sian,
  • Wilson Wen Bin Goh,
  • Wei-Ping Yu,
  • Li Li,
  • Valerie C. L. Lin

DOI
https://doi.org/10.1186/s12915-022-01410-3
Journal volume & issue
Vol. 20, no. 1
pp. 1 – 18

Abstract

Read online

Abstract Background Progesterone receptor (PGR) is a master regulator of uterine function through antagonistic and synergistic interplays with oestrogen receptors. PGR action is primarily mediated by activation functions AF1 and AF2, but their physiological significance is unknown. Results We report the first study of AF1 function in mice. The AF1 mutant mice are infertile with impaired implantation and decidualization. This is associated with a delay in the cessation of epithelial proliferation and in the initiation of stromal proliferation at preimplantation. Despite tissue selective effect on PGR target genes, AF1 mutations caused global loss of the antioestrogenic activity of progesterone in both pregnant and ovariectomized models. Importantly, the study provides evidence that PGR can exert an antioestrogenic effect by genomic inhibition of Esr1 and Greb1 expression. ChIP-Seq data mining reveals intermingled PGR and ESR1 binding on Esr1 and Greb1 gene enhancers. Chromatin conformation analysis shows reduced interactions in these genes’ loci in the mutant, coinciding with their upregulations. Conclusion AF1 mediates genomic inhibition of ESR1 action globally whilst it also has tissue-selective effect on PGR target genes.

Keywords